Literature DB >> 12590958

ABO blood group distribution and severity of coronary artery disease among patients undergoing coronary artery bypass surgery in Northern Finland.

Fausto Biancari1, Jari Satta, Risto Pokela, Tatu Juvonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12590958     DOI: 10.1016/s0049-3848(03)00003-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?

Authors:  Shan Zhou; Ian Welsby
Journal:  World J Cardiol       Date:  2014-09-26

2.  ABO Gene Polymorphism and Thrombomodulin -33G>A Polymorphism Were Not Risk Factors for Myocardial Infarction in Javanese Men.

Authors:  Mifetika Lukitasari; Ahmad Hamim Sadewa; Mohammad Saifur Rohman
Journal:  Int J Vasc Med       Date:  2017-07-24

3.  Association of ABO blood groups with the severity of coronary artery disease: a cross-sectional study.

Authors:  Xu-Lin Hong; Ya Li; Guo-Sheng Fu; Heng Wu; Yao Wang; Chun-Xia Gu; Wen-Bin Zhang
Journal:  J Geriatr Cardiol       Date:  2019-09       Impact factor: 3.327

4.  Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

Authors:  Zixiang Ye; Yaxin Wu; Yimin Tu; Mulei Chen; Yanxiang Gao; Linying Shi; Peizhao Li; Enmin Xie; Ziyu Guo; Qing Li; Xiaozhai Yu; Yike Li; Wenquan Niu; Jingyi Ren; Jingang Zheng
Journal:  Front Cardiovasc Med       Date:  2022-01-28

5.  The association of ABO blood groups with extent of coronary atherosclerosis in Croatian patients suffering from chronic coronary artery disease.

Authors:  Svjetlana Karabuva; Vedran Carević; Mislav Radić; Damir Fabijanić
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

6.  Blood group A: a risk factor for heart rupture after acute myocardial infarction.

Authors:  Yuan Fu; Mulei Chen; Hao Sun; Zongsheng Guo; Yuanfeng Gao; Xinchun Yang; Kuibao Li; Lefeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.